Finance

Lists
FME:ETR
Fresenius Medical Care AG
40,11 €
+1,39%
(+0,55) 1D
13 ნოე, 17:35:24 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for FME...
Open
39,10 €
High
40,18 €
Low
39,01 €
Mkt. cap
10,66 მლრდ.
Avg. vol.
1,03 მლნ.
Volume
962,24 ათ.
Dividend
3,71%
Quarterly dividend
0,37 €
Ex-dividend date
22 მაი. 2026
P/E ratio
13,40
52-wk high
45,90 €
52-wk low
34,57 €
EPS
2,99 €
Shares outstanding
268,56 მლნ.
No. of employees
106 ათ.
Open
39,10 €
High
40,18 €
Low
39,01 €
Mkt. cap
10,66 მლრდ.
Avg. vol.
1,03 მლნ.
Volume
962,24 ათ.
Dividend
3,71%
Quarterly dividend
0,37 €
Ex-dividend date
22 მაი. 2026
P/E ratio
13,40
52-wk high
45,90 €
52-wk low
34,57 €
EPS
2,99 €
Shares outstanding
268,56 მლნ.
No. of employees
106 ათ.
News stories
From web sources and news partners
Profile
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease, which requires patients to undergo dialysis 3 times per week for the rest of their lives. With a global headquarters in Bad Homburg vor der Höhe, Germany, and a North American headquarters in Waltham, Massachusetts, it has a 38% market share of the dialysis market in the United States. It also operates 42 production sites, the largest of which are in the U.S., Germany, and Japan. The company is 32% owned by Fresenius and, as of 2020, generates around 50% of the group's revenue. As of 2024, the company was ranked as #612 on the World's Best Employers list published by Forbes. Wikipedia
About Fresenius Medical Care AG
CEOჰელენ გიზა
Employees106 ათ.
Founded1996
Headquarters-
SectorHealth Care
IndustryHealth care provider
Last report
3 ნოე. 2026
Fiscal period
Q3 2026
0,56 € / 1,20 €
-53,77%miss
Revenue / Est. (EUR)
4,94 მლრდ. / 4,91 მლრდ.
+0,50%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
დეკ. 2025
მარ. 2026
ივნ. 2026
სექ. 2026
Revenue
5,07 მლრდ.
4,61 მლრდ.
4,86 მლრდ.
4,94 მლრდ.
Cost of goods sold
3,68 მლრდ.
3,43 მლრდ.
3,55 მლრდ.
3,66 მლრდ.
Cost of revenue
3,68 მლრდ.
3,43 მლრდ.
3,55 მლრდ.
3,66 მლრდ.
Research and development expenses
38,63 მლნ.
38,31 მლნ.
39,63 მლნ.
41,40 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
784,62 მლნ.
748,94 მლნ.
736,01 მლნ.
743,60 მლნ.
Operating expense
796,34 მლნ.
803,94 მლნ.
786,35 მლნ.
799,91 მლნ.
Total operating expenses
4,48 მლრდ.
4,24 მლრდ.
4,34 მლრდ.
4,46 მლრდ.
Operating income
592,03 მლნ.
375,56 მლნ.
523,63 მლნ.
475,46 მლნ.
Other non operating income
-
-
-
-
EBT including unusual items
508,46 მლნ.
207,52 მლნ.
383,00 მლნ.
302,63 მლნ.
EBT excluding unusual items
541,79 მლნ.
334,44 მლნ.
399,22 მლნ.
405,36 მლნ.
Income tax expense
106,44 მლნ.
42,75 მლნ.
89,83 მლნ.
77,84 მლნ.
Effective tax rate
20,93%
20,60%
23,45%
25,72%
Other operating expenses
-26,91 მლნ.
16,69 მლნ.
10,71 მლნ.
14,91 მლნ.
Net income
327,08 მლნ.
117,53 მლნ.
218,38 მლნ.
159,78 მლნ.
Net profit margin
6,45%
2,55%
4,49%
3,24%
Earnings per share
1,44
0,91
0,56
0,56
Interest and investment income
13,62 მლნ.
14,62 მლნ.
14,70 მლნ.
16,05 მლნ.
Interest expense
-99,02 მლნ.
-93,30 მლნ.
-97,55 მლნ.
-97,50 მლნ.
Net interest expenses
-85,40 მლნ.
-78,68 მლნ.
-82,86 მლნ.
-81,46 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
780,17 მლნ.
727,79 მლნ.
879,38 მლნ.
829,79 მლნ.
Gain or loss from assets sale
17,92 მლნ.
8,77 მლნ.
-4,09 მლნ.
-7,18 მლნ.
Upcoming events
AI content may include mistakes. Learn more
Google აპები